- Home
- AVTX vs INLX Comparison
AVTX vs INLX Comparison
Compare AVTX & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- INLX
- Stock Information
- Founded
- AVTX 2011
- INLX 1996
- Country
- AVTX United States
- INLX United States
- Employees
- AVTX N/A
- INLX N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- INLX EDP Services
- Sector
- AVTX Health Care
- INLX Technology
- Exchange
- AVTX Nasdaq
- INLX Nasdaq
- Market Cap
- AVTX 57.4M
- INLX 53.5M
- IPO Year
- AVTX 2015
- INLX N/A
- Fundamental
- Price
- AVTX $7.89
- INLX $12.05
- Analyst Decision
- AVTX Strong Buy
- INLX
- Analyst Count
- AVTX 7
- INLX 0
- Target Price
- AVTX $31.00
- INLX N/A
- AVG Volume (30 Days)
- AVTX 149.3K
- INLX 1.9K
- Earning Date
- AVTX 08-11-2025
- INLX 08-12-2025
- Dividend Yield
- AVTX N/A
- INLX N/A
- EPS Growth
- AVTX N/A
- INLX N/A
- EPS
- AVTX N/A
- INLX N/A
- Revenue
- AVTX $441,000.00
- INLX $17,758,634.00
- Revenue This Year
- AVTX N/A
- INLX $2.47
- Revenue Next Year
- AVTX N/A
- INLX $7.72
- P/E Ratio
- AVTX $1.17
- INLX N/A
- Revenue Growth
- AVTX N/A
- INLX 3.21
- 52 Week Low
- AVTX $3.39
- INLX $7.75
- 52 Week High
- AVTX $16.00
- INLX $16.50
- Technical
- Relative Strength Index (RSI)
- AVTX 80.64
- INLX 40.87
- Support Level
- AVTX $6.21
- INLX $12.95
- Resistance Level
- AVTX $6.89
- INLX $13.66
- Average True Range (ATR)
- AVTX 0.64
- INLX 0.46
- MACD
- AVTX 0.17
- INLX -0.18
- Stochastic Oscillator
- AVTX 78.59
- INLX 0.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.